-
-
-
-
-
-
-
Florida sues Pfizer over Covid-19 vaccine safety claims
-
-
-
-
-
-
-
Pfizer Q2 earnings preview: Analysts eye pipeline updates, portfolio resilience
-
-
-
-
-
-
-
HSBC Downgrades Pfizer (PFE) to Hold
-
-
-
-
-
-
-
Pfizer reaffirms 2026 guidance after CFO transition news
-
-
-
-
-
-
-
Pfizer's BRAFTOVI regimen shows improved survival in colorectal cancer
-
-
-
-
-
-
-
Arvinas and Pfizer sell VEPPANU rights to Rigel for $85 million upfront
-
-
-
-
-
-
-
Pfizer beats first quarter estimates on strong product growth
-
481,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


